# OnCo record bd200 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bd200/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bd200" ;
  schema:name "BD200"@en ;
  schema:description "BD200 is an experimental multibody-drug conjugate from Biolojic Design, in phase 1 trials for select unresectable locally advanced or metastatic solid cancers."@en ;
  schema:url <https://onco.cc/drugs/bd200/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://biolojic.com/pipeline/>, <https://clinicaltrials.gov/api/v2/studies/NCT07797907>, <https://clinicaltrials.gov/search?intr=BD200> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Multibody-drug conjugate (dual-binding IgG antibody-drug conjugate)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/nectin4/> ;
  onco:companies <https://onco.cc/companies/biolojic-design/> ;
  onco:trials <https://onco.cc/trials/nct07797907/> .